PLX
Protalix BioTherapeutics, Inc. Common Stock
$2.19
-0.90%
-0.02
Notify me if price changes either direction
Buy PLX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
177.3M
Enterprise value
156.9M
Trailing PE
26.750002
Forward PE
3.580645
PEG Ratio
3.580645
Enterprise to EBITDA
-38.889
Enterprise to revenue
2.975
Price to book MRQ
3.6999998
Price to sales TTM
3.391268
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
52.7M
EBITDA
-4035000
Diluted EPS TTM
-0.08
Total Cash (MRQ)
30.3M
Current ratio (MRQ)
2.514
Operating Cash Flow (TTM)
-11993000
PLX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
